A Phase 1b, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Sequential Dose Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease on Donepezil
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2011
At a glance
- Drugs ASP 0777 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 17 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Sep 2011 Planned End Date changed from 1 Dec 2011 to 1 Nov 2011 as reported by ClinicalTrials.gov.
- 22 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.